Pacific Biosciences
PACB
#6557
Rank
ยฃ0.54 B
Marketcap
ยฃ1.79
Share price
-5.16%
Change (1 day)
12.59%
Change (1 year)

Revenue for Pacific Biosciences (PACB)

Revenue in 2025 (TTM): ยฃ0.11 Billion

According to Pacific Biosciences 's latest financial reports the company's current revenue (TTM ) is ยฃ0.11 Billion. In 2024 the company made a revenue of ยฃ0.12 Billion a decrease over the revenue in the year 2023 that were of ยฃ0.15 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Pacific Biosciences from 2010 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ0.11 B-4.21%
2024 ยฃ0.12 B-22.02%
2023 ยฃ0.15 B48.41%
2022 ยฃ0.10 B9.69%
2021 ยฃ96.68 M67.05%
2020 ยฃ57.87 M-16.5%
2019 ยฃ69.31 M11.9%
2018 ยฃ61.94 M-10.44%
2017 ยฃ69.15 M-5.93%
2016 ยฃ73.51 M17.42%
2015 ยฃ62.6 M60.87%
2014 ยฃ38.91 M127.81%
2013 ยฃ17.08 M6.27%
2012 ยฃ16.07 M-26.21%
2011 ยฃ21.78 M1909.11%
2010 ยฃ1.08 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Illumina
ILMN
ยฃ3.21 B 2,673.90%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoString Technologies
NSTG
ยฃ0.12 B 5.10%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
ยฃ32.96 B 28,329.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Luminex
LMNX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
ยฃ32.80 B 28,192.06%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
ยฃ2.51 B 2,071.93%๐Ÿ‡บ๐Ÿ‡ธ USA